Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Jan 03, 2024 |
referred to health |
Feb 16, 2023 |
referred to health |
Senate Bill S4870
2023-2024 Legislative Session
Sponsored By
(R) 43rd Senate District
Current Bill Status - In Senate Committee Health Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
2023-S4870 (ACTIVE) - Details
2023-S4870 (ACTIVE) - Summary
Relates to patient counseling before issuing a prescription for a schedule II opioid; requires practitioners to consult with the patient regarding the quantity of the opioid and the patient's option to fill the prescription in a lesser quantity, and to inform the patient of the risks associated with opiate addiction and document the reason for the prescription.
2023-S4870 (ACTIVE) - Sponsor Memo
BILL NUMBER: S4870 SPONSOR: ASHBY PURPOSE OR GENERAL IDEA OF BILL: This bill will authorize a practitioner to consult with a patient in regards to the quantity of an opioid prescribed. SUMMARY OF PROVISIONS: The bill's provisions establish that a practitioner - prior to prescrib- ing a schedule II opioid - must take the following 3 steps: (1) consult with the patient in regards to the quantity of an opioid, as well as the patient's option to fill the prescription in a lesser quan- tity;. (2) inform the patient about the risks associated with an opioid-related addiction; and (3) document the reason for the prescription in the patient's medical record.
2023-S4870 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 4870 2023-2024 Regular Sessions I N S E N A T E February 16, 2023 ___________ Introduced by Sen. ASHBY -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law, in relation to patient counseling before issuing a prescription for a schedule II opioid THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Section 3331 of the public health law is amended by adding a new subdivision 2-a to read as follows: 2-A. PRIOR TO ISSUING A PRESCRIPTION FOR A SCHEDULE II OPIOID, A PRAC- TITIONER SHALL: (A) CONSULT WITH THE PATIENT REGARDING THE QUANTITY OF THE OPIOID AND THE PATIENT'S OPTION TO FILL THE PRESCRIPTION IN A LESSER QUANTITY; (B) INFORM THE PATIENT OF THE RISKS ASSOCIATED WITH OPIATE ADDICTION; AND (C) DOCUMENT THE REASON FOR THE OPIOID PRESCRIPTION IN THE PATIENT'S MEDICAL RECORD. § 2. This act shall take effect on the ninetieth day after it shall have become a law. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD00919-01-3
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.